Literature DB >> 18299857

[Juvenile idiopathic arthritis--clinical subgroups and classification].

K Minden1, M Niewerth.   

Abstract

There have been major advances in the field of paediatric rheumatology over the last 15 years, which have included improvements in the classification of chronic arthritis, the most common chronic rheumatic disease in children and adolescents. A new classification was proposed by the International League of Associations for Rheumatology (ILAR) in 1995, which facilitated collaborative research and comparability of study results. According to the ILAR classification juvenile idiopathic arthritis (JIA) is a new term that encompasses the heterogeneous forms of arthritis of unknown cause, which begin before 16 years of age. The JIA classification identifies seven disease categories, which differ in their clinical presentation, outcome, and in some cases, genetic background, and which are characterized here on the basis of data from the national paediatric rheumatology database. Despite its usefulness for international research, the ILAR classification also has restrictions and further revision is therefore required. A special problem with a need for a solution is represented by the limited application in adult rheumatology.

Entities:  

Mesh:

Year:  2008        PMID: 18299857     DOI: 10.1007/s00393-007-0246-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  28 in total

Review 1.  Juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Alberto Martini
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

2.  Use of contrast-enhanced MR imaging to detect sacroiliitis in children.

Authors:  M Bollow; J Braun; T Biedermann; S Mutze; S Paris; C Schauer-Petrowskaja; K Minden; S A Schmitz; M Schöntube; B Hamm
Journal:  Skeletal Radiol       Date:  1998-11       Impact factor: 2.199

3.  Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997.

Authors:  R E Petty; T R Southwood; J Baum; E Bhettay; D N Glass; P Manners; J Maldonado-Cocco; M Suarez-Almazor; J Orozco-Alcala; A M Prieur
Journal:  J Rheumatol       Date:  1998-10       Impact factor: 4.666

4.  Subtyping of juvenile idiopathic arthritis using latent class analysis. British Paediatric Rheumatology Group.

Authors:  E Thomas; J H Barrett; R P Donn; W Thomson; T R Southwood
Journal:  Arthritis Rheum       Date:  2000-07

5.  Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines.

Authors:  A Heiligenhaus; M Niewerth; G Ganser; C Heinz; K Minden
Journal:  Rheumatology (Oxford)       Date:  2007-04-02       Impact factor: 7.580

6.  Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology. European League Against Rheumatism.

Authors:  L Berntson; A Fasth; B Andersson-Gäre; J Kristinsson; P Lahdenne; G Marhaug; S Nielsen; P Pelkonen; E Svensson
Journal:  J Rheumatol       Date:  2001-12       Impact factor: 4.666

7.  Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease.

Authors:  Angelo Ravelli; Enrico Felici; Silvia Magni-Manzoni; Angela Pistorio; Cristina Novarini; Elena Bozzola; Stefania Viola; Alberto Martini
Journal:  Arthritis Rheum       Date:  2005-03

Review 8.  Classification criteria in rheumatic diseases: a review of methodologic properties.

Authors:  Sindhu R Johnson; Oemer-Necmi Goek; Davinder Singh-Grewal; Steven C Vlad; Brian M Feldman; David T Felson; Gillian A Hawker; Jasvinder A Singh; Daniel H Solomon
Journal:  Arthritis Rheum       Date:  2007-10-15

9.  The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families.

Authors:  Emma M Ogilvie; Mark S Fife; Susan D Thompson; Natalie Twine; Monica Tsoras; Marta Moroldo; Sheila A Fisher; Cathryn M Lewis; Anne-Marie Prieur; David N Glass; Patricia Woo
Journal:  Arthritis Rheum       Date:  2003-11

Review 10.  Clinical utility of antinuclear antibody tests in children.

Authors:  Julie L McGhee; Lauren M Kickingbird; James N Jarvis
Journal:  BMC Pediatr       Date:  2004-07-09       Impact factor: 2.125

View more
  6 in total

Review 1.  [Imaging options in pediatric rheumatology].

Authors:  D Windschall
Journal:  Z Rheumatol       Date:  2016-12       Impact factor: 1.372

Review 2.  [Adolescent rheumatism : The same but different].

Authors:  Sabine Adler
Journal:  Z Rheumatol       Date:  2018-10       Impact factor: 1.372

Review 3.  [Clinical features and therapy of rheumatic diseases and vasculitides in childhood].

Authors:  K Tenbrock
Journal:  Hautarzt       Date:  2014-09       Impact factor: 0.751

Review 4.  Juvenile idiopathic arthritis: new insights into classification, measures of outcome, and pharmacotherapy.

Authors:  Michael W Beresford
Journal:  Paediatr Drugs       Date:  2011-06-01       Impact factor: 3.022

5.  Exposure to animals and risk of oligoarticular juvenile idiopathic arthritis: a multicenter case-control study.

Authors:  Katja Radon; Doris Windstetter; David Poluda; Renate Häfner; Silke Thomas; Hartmut Michels; Erika von Mutius
Journal:  BMC Musculoskelet Disord       Date:  2010-04-20       Impact factor: 2.362

6.  [Transitional care in rheumatology in Germany].

Authors:  S Schalm; A F Jansson
Journal:  Internist (Berl)       Date:  2012-09       Impact factor: 0.743

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.